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Abstract
Background: The endocardial endothelium that lines the inner cavity of the heart is distinct from
the microvascular endothelial cells and modulates cardiac muscle performance in a manner similar
to the vascular endothelial modulation of vascular structure and vasomotor tone. Although the
modulatory effects of endocardial endothelium (EE) on cardiomyocytes are firmly established, the
regulatory effects of endocardial endothelium on the cardiac interstitium and its cellular
components remain ill defined.
Methods and Results: We investigated whether the stimulatory effect of EE on cardiac
fibroblasts would be altered when EECs are activated by the cytokine tumor necrosis factor-α
(TNF-α) or the endotoxin bacterial lipopolysaccharide (LPS). Both TNF-α and LPS were found to
independently attenuate the stimulatory effect of EE on cardiac fibroblasts. These agents lowered
the synthesis or release of ET-1 and increased the secretion of TGF-β and NO.
Conclusion: The findings of this study using endocardial endothelial cells (EECs) and neonatal
cardiac fibroblasts demonstrate that pro-inflammatory cytokines cause altered secretion of
paracrine factors by EECs and inhibit proliferation and lower collagen synthesis in fibroblasts. These
changes may influence fibroblast response and extra cellular matrix remodeling in pathological
conditions of the heart.
Background
The endocardial endothelium (EE) that lines the inner
cavity of the heart is distinct from the microvascular
endothelial cells in terms of embryological origin,
cytoskeletal organization, receptor – mediated functions,
electrophysiological properties, release of prostanoids
and growth characteristics in culture [1]. The EE is strate-
gically situated between the circulating blood and the car-
diac muscle and it modulates cardiac muscle performance
exactly as the vascular endothelium modulates vascular
structure and vasomotor tone. Brutsaert et al [2] have
demonstrated that EE is an important modulator of sub-
jacent cardiac muscle performance. Dysfunction of this
interface could be a critical factor in various pathological
conditions of the heart. Evidence of physiologically signif-
icant paracrine interactions between the endocardial cell
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studies on factors of endothelial origin such as endothe-
lins, angiotensin II, nitric oxide (NO), natriuretic pep-
tides, bradykinin prostaglandins, adenylpurines,
myofilament desensitizing element and enzymes such as
angiotensin converting enzyme and kininase. Impor-
tantly, an imbalance in the turnover of these factors in car-
diovascular diseases may potentially promote alterations
in the extra cellular matrix (ECM) and disturb cardiomyo-
cyte function. In fact, heart function is reported to be sig-
nificantly affected by increased cytokine production in a
setting of endotoxic shock, transplant rejection and
ischemia/reperfusion [3]. Endothelium derived factors
such as TNF-α, IL-1β, IL-6 and TGF-β may exert autocrine
and paracrine effects on fibroblast growth and collagen
turnover as well.
Whereas the modulatory influence of EE on cardiomyo-
cytes is well established, the effects of EE on the cardiac
interstitium and its cellular components particularly the
fibroblasts, which maintain the extracellular matrix
homeostasis are far less defined [4]. In this regard, we had
recently reported a significant increase in cardiac fibrob-
last proliferation and collagen synthesis when the cells are
grown in EEC conditioned media [5]. In the present study,
we investigated whether the stimulatory effect of EE on
cardiac fibroblasts would be altered in conditions where
TNF-α or the endotoxin bacterial LPS activates EECs. Our
results suggest that TNF-α or LPS – activated EE cells atten-
uate proliferation and collagen synthesis in cardiac
fibroblasts.
Materials and methods
Tissue culture media and all supplements were procured
from Sigma-Aldrich, St. Louis, USA. [3H]-Thymidine and
[3H]-Proline was obtained from Board of Radioactivity
and Isotope Technology (BRIT), Mumbai, India. DiI-
Acetylated LDL was purchased from Molecular Probes,
Netherlands.
Preparation of cultures of endocardial endothelial cells
Endocardial endothelial cells were isolated from freshly
collected pig hearts by the method previously described
by Smith et al [6]. Briefly, the ventricles were filled with
0.1% collagenase (Type IA) in medium E199 and incu-
bated for 45 minutes. The released cells were resuspended
in complete medium (medium E199 supplemented with
20% fetal bovine serum (FBS), 1% endothelial cell growth
factor, 100 U/ml benzyl penicillin and 100 μg/ml strepto-
mycin) and seeded in gelatin – coated culture dishes. Con-
fluent cultures were sub – cultured using 0.025% trypsin
– 0.02% EDTA. The cells were identified as endothelial
cells by their cobblestone appearance, positive staining
for factor VIII antigen and incorporation of DiI-acetylated
low-density lipoproteins.
Preparation of cultures of cardiac fibroblasts
Cardiac fibroblasts were isolated from 3- to 4-day-old
Wistar rat pups. The heart tissue was minced and digested
with 0.03 % collagenase and 0.03 % trypsin. The superna-
tants were centrifuged and cell pellet was resuspended in
medium M199 with 10% FBS. Cardiac fibroblasts
attached within 90 minutes. The cells were grown to con-
fluence and passaged with 0.025% trypsin-0.02% EDTA
mixture. The cells were identified as fibroblasts by their
spindle morphology, positive staining for vimentin and
negative staining for factor VIII antigen.
All experiments had the approval of the Institutional Ani-
mal Ethics Committee.
Preparation of conditioned medium
The experiments were performed on EECs from the 3rd –
4th passages. Cells were seeded at a density of 2 × 105 cells/
ml in 35 mm culture dishes. At confluence, the cells were
made quiescent by reducing the serum content of the
medium to 0.4% for 24 hours. On the day of the experi-
ment, the cells were washed with phosphate – buffered
saline and treated with either 10 ng/ml TNF-α or 1 μg/ml
bacterial LPS. Cells incubated in 0.4% FBS containing
medium served as control. At the end of the incubation
period of 24 hours, the medium was collected, centrifuged
to remove cellular debris and stored at -80°C until use.
Dulbecco's modified Eagle's medium (DMEM) was used
for generating conditioned medium for the collagen syn-
thesis experiments.
Proliferation assay
DNA synthesis in cardiac fibroblasts was measured in
terms of [3H]-Thymidine incorporation into DNA (n =
15) as described earlier [7]. Cells were seeded at a density
of 1 × 105 cells/ml and incubated for 24 hours. Cells from
passage 2 were made quiescent by incubating them in
medium containing 0.4% FBS for 24 hours. Following
incubation of the cells with [3H]-Thymidine at a final con-
centration of 1 μCi/ml for 24 hours, acid – insoluble radi-
oactivity was determined by using liquid scintillation
spectrometry.
Collagen synthesis assay
Incorporation of [3H]-Proline by cardiac fibroblasts was
taken as a measure of collagen synthesis (n = 9). Cardiac
fibroblasts at confluence were incubated in DMEM sup-
plemented with 0.4% FBS, 24 hours prior to treatment.
Subsequently, cells were incubated for 24 hours in either
0.4% FBS or EEC – conditioned medium, containing 2
μCi/ml [3H]-Proline and 50 μg/ml ascorbic acid in
DMEM. The supernatant was collected and cells were
lysed using 1% Triton-X 100 containing 5 mM N-ethyl-
maleimide. The cell lysate and medium were pooled and
the mixture divided into two aliquots. Proteins in onePage 2 of 7
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ond aliquot was digested with 30 μg/ml collagenase Type
VII in Tris-CaCl2 buffer (pH – 7.4) for 5 hours at 37°C. At
the end of collagenase digestion, the proteins were precip-
itated with 10% ice-cold TCA. The TCA-precipitated mate-
rial in the two aliquots was filtered separately onto
Whatman no.3 filter paper. Radioactivity was determined
using a scintillation counter. Collagen synthesis was cal-
culated using the equation:
A correction factor of f = 5.4 for non-collagen protein was
used to adjust for the relative abundance of proline and
hydroxyproline in collagen containing proteins [8].
Measurement of EEC – derived factors in the conditioned 
medium
The conditioned medium was assayed (n = 6) for the lev-
els of EEC – derived factors, ET-1 (Cayman Chemical, MI,
USA), Ang II (SPI BIO, France) and TGF-β1 (Biosource
International, Belgium) by ELISA using commercially
available kits.
Statistics
Sample means were compared using Student's t-test.
ANOVA was employed for group comparisons where
there were more than two groups. The values are expressed
as mean ± SD. p < 0.05 was considered statistically signif-
icant.
Results
Effect of TNF-α and LPS on EEC-induced proliferation of 
cardiac fibroblasts
On incubation with EE – conditioned medium, [3H]-Thy-
midine incorporation into cardiac fibroblast DNA
increased by 22%. The stimulatory effect was however
attenuated when cardiac fibroblasts were incubated in
medium conditioned by TNF-α or LPS treated EECs. [3H]-
Thymidine counts per minute (cpm) with medium condi-
tioned by untreated EECs was 49678 ± 418.7. [3H]-Thymi-
dine counts per minute (cpm) with medium conditioned
by EECs treated with TNF-α or LPS were 45271.7 ± 1008.7
cpm and 45163.6 ± 802.5 cpm respectively. The basal
[3H]-Thymidine counts per minute (cpm) with 0.4%
M199 was 40676 ± 985 cpm. Thus, TNF-α treated EECs
attenuated [3H]-Thymidine incorporation into DNA of
cardiac fibroblasts by 11.3 % (n = 15; p < 0.01) and LPS
treated EECs attenuated [3H]-Thymidine incorporation
into DNA of cardiac fibroblasts by 11% (n = 15; p < 0.01)
(Figure 1).
Effect of TNF-α and LPS on EEC-induced collagen 
synthesis by cardiac fibroblasts
The effect of medium conditioned by TNF-α or LPS
treated EECs, on collagen synthesis by cardiac fibroblasts
is shown in Figure 2. The basal rate of collagen synthesis
by cardiac fibroblasts in 0.4% M199 was 6.51 ± 1.0 % of
the total protien and by fibroblasts grown in medium con-
ditioned by untreated EECs was 10.6 ± 0.9 % of the total
protien. Collagen synthesis by cardiac fibroblasts was
reduced to 4.85 ± 0.9 % and 5.12 ± 1 % of the total pro-
tein respectively when the cells were grown in medium
conditioned by TNF-α or LPS treated EECs (n = 6; Con-
trol-CM vs TNF-CM and LPS-CM, p < 0.05). Whereas a 6
% increase in collagen synthesis was seen in fibroblasts
grown in medium conditioned by untreated EECs, rate of
collagen synthesis in cardiac fibroblasts incubated with
conditioned medium from EECs treated with TNF-α or
LPS was seen to decrease by 25% and 21% respectively,
compared to the control (Figure 2).
Collagen (% of total protein)
Collagenase released cpm  
=
× 100
( )Non-collagen cpm  f   collagenase released cpm× +
(3H)-Thymidine uptake by cardiac fibroblasts incubated with conditioned m dium from EECs treated wi h TNF-α and LPSFigure 1
(3H)-Thymidine uptake by cardiac fibroblasts incu-
bated with conditioned medium from EECs treated 
with TNF-α and LPS. The values are mean ± SD (n = 15; 
Control-CM vs TNF-CM & Control-CM vs LPS-CM, *p < 
0.01. Control-CM vs. 0.4% M199, *p < 0.01). Control-CM = 
Fibroblasts grown in conditioned medium from untreated 
endocardial endothelial cells, TNF-CM = Fibroblasts grown 
in conditioned medium from endocardial endothelial cells 
treated with TNF-α, LPS-CM = Fibroblasts grown in condi-
tioned medium from endocardial endothelial cells treated 
with LPS, 0.4% M199 = Fibroblasts grown in M199 containing 
0.4% FBS. 'n' is the number of times each experiment was 
done.Page 3 of 7
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the culture supernatants
Levels of endothelium-derived factors ET-1, AII, and TGF-
β1, were determined by ELISA according to the manufac-
turer's protocols. NO released into the medium was meas-
ured as nitrite by Griess reaction.
Treatment of EECs with TNF-α and LPS caused increased
release of nitrite from the cells into the culture superna-
tant. The amount of nitrite released into the medium con-
ditioned by untreated EECs was 1.81 ± 0.17 μM. TNF-α or
LPS treatment of EECs increased nitrite levels in the cul-
ture supernatant to 2.86 ± 0.29 μM and 4.48 ± 0.44 μM
respectively (n = 6; p < 0.05). Thus, stimulation of EECs
with TNF-α or LPS increased nitrite release from EECs by
58% and 147% respectively (Figure 3).
ET-1 levels and TGF-β levels in the culture supernatant of
EECs treated with TNF-α were 5.56 ± 0.02 ng/ml and 7.21
± 0.1 ng/ml respectively compared to ET -1 and TGF-β lev-
els of 6.6 ± 0.01 ng/ml and 6.56 ± 0.05 ng/ml respectively
in the culture supernatant of untreated EECs (n = 6; p <
0.01). Thus, TNF-α depressed the release of ET-1 by 16%
but increased TGF-β release by 10% from EECs.
When EECs were treated with LPS, the ET-1 levels in the
culture supernatant was 6.1 ± 0.03 ng/ml and TGF-β levels
were 5.66 ± 0.08 ng/ml compared to the ET-1 levels of
6.63 ± 0.01 ng/ml and TGF-β levels of 6.56 ± 0.05 ng/ml
in the culture supernatant of untreated EECs (n = 6; p <
0.01). Thus, treatment of EECs with LPS reduced ET-1
secretion by 8% and TGF-β secretion by 13.7% (Figures 4
and 5).
Angiotensin II levels were undetectable in all the culture
supernatants.
Discussion
It is well recognized that vascular endothelial cells exert
marked regulatory influence on subjacent non-endothe-
lial cells such as myocytes, fibroblasts, pericytes and
smooth muscle cells (SMCs) [9-13]. Given the regional
differences in the functional properties of the endothe-
Collagen synthesis by cardiac fibroblasts in response to incu-bation with cond tioned medium from endocardial ndothe-li l cells treated with TNF-α and LPS for 24 hoursFigur  2
Collagen synthesis by cardiac fibroblasts in response 
to incubation with conditioned medium from endo-
cardial endothelial cells treated with TNF-α and LPS 
for 24 hours. The values are mean ± SD (n = 6; Control-CM 
vs TNF-CM and LPS-CM, *p < 0.05. Control-CM vs 0.4% 
M199 *p < 0.05). Control-CM = Fibroblasts grown in condi-
tioned medium from untreated endocardial endothelial cells, 
TNF-CM = Fibroblasts grown in conditioned medium from 
endocardial endothelial cells treated with TNF-α, LPS-CM = 
Fibroblasts grown in conditioned medium from endocardial 
endothelial cells treated with LPS, 0.4% M199 = Fibroblasts 
grown in M199 containing 0.4% FBS. 'n' is the number of 
times each experiment was done.
Nitrite release by endocardial endothelial cells in response to proinflamm tory agents TNF-α and LPSFigur  3
Nitrite release by endocardial endothelial cells in 
response to proinflammatory agents TNF-α and LPS. 
The values are mean ± SD (n = 6;*p < 0.05). Control-CM = 
Conditioned medium from untreated endocardial endothelial 
cells, TNF-CM = Conditioned medium from endocardial 
endothelial cells treated with TNF-α, LPS-CM = Conditioned 
medium from endocardial endothelial cells treated with LPS. 
'n' is the number of times each experiment was done.Page 4 of 7
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lating cardiac fibroblast proliferation and collagen
synthesis and found that EE has a stimulatory effect on
cardiac fibroblasts [5]. In the present study we explored
whether pro – inflammatory agents such as TNF-α and
LPS modulate this stimulatory effect. Interestingly, both
TNF-α and LPS were found to attenuate the stimulatory
effect of EE on cardiac fibroblasts.
The inflammatory effects of TNF-α and LPS on vascular
endothelial cells are well – characterized. Endothelial cells
obtained from different sites exhibit varied responses to
cytokines and LPS [14]. However, the effects of TNF-α and
LPS on endocardial endothelial cells have not been previ-
ously reported.
In the present study, [3H]-Thymidine incorporation as
well as rate of collagen synthesis were significantly lower
in cardiac fibroblasts grown in conditioned medium from
EECs treated with either TNF-α or LPS, when compared to
the cells grown in EEC conditioned medium and not
treated with either agents. Neither TNF-α nor LPS affected
the viability of the cells. Concentrations of TNF-α up to
1000 ng/ml have been reported to cause reduction in col-
lagen synthesis in cardiac fibroblasts without affecting the
cell numbers [15]. Our study demonstrated not only the
direct inhibitory action of TNF-α on collagen synthesis in
cardiac fibroblasts, but also its ability to attenuate the
stimulatory effect of EECs on collagen production by car-
diac fibroblasts. Yokoyama et al [16] proposed that TNF-
α could act as an autocrine/paracrine mediator in myocar-
dial remodeling. The cytokine increases both the expres-
sion and activity of matrix metalloproteinases (MMPs)
which regulate matrix turnover [17]. In studies investigat-
ing the direct effect of TNF-α on cardiac fibroblasts, it has
been observed that the cytokine decreases total collagen
synthesis [18,19].
We also observed alterations in the release of endothe-
lium-derived factors, such as NO, TGF-β and ET-1 into the
conditioned medium when EECs were treated with TNF-a
or LPS, which in turn could contribute to the altered
response elicited in cardiac fibroblasts treated with the
conditioned medium. EECs released significantly higher
levels of nitrite in response to the pro-inflammatory
agents. A notable action of TNF-α is its ability to induce
nitric oxide synthase (NOS) activity in different cell types,
including endocardial cells [6,20]. Nitric oxide (NO) is an
Effect of TNF-α and LPS on ET-1 release by endocardial endothelial cellsFigure 4
Effect of TNF-α and LPS on ET-1 release by endocar-
dial endothelial cells. The values are mean ± SD (n = 6;*p 
< 0.01). Control-CM = Conditioned medium from untreated 
endocardial endothelial cells, TNF-CM = Conditioned 
medium from endocardial endothelial cells treated with TNF-
α, LPS-CM = Conditioned medium from endocardial 
endothelial cells treated with LPS. 'n' is the number of times 
each experiment was done.
Effect of TNF-α and LPS on TGF-β release by endocardial endothelial cellsFigure 5
Effect of TNF-α and LPS on TGF-β release by endo-
cardial endothelial cells. The values are mean ± SD (n = 
6;*p < 0.01). Control-CM = Conditioned medium from 
untreated endocardial endothelial cells, TNF-CM = Condi-
tioned medium from endocardial endothelial cells treated 
with TNF-α, LPS-CM = Conditioned medium from endocar-
dial endothelial cells treated with LPS. 'n' is the number of 
times each experiment was done.Page 5 of 7
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being an immunomodulator and a potent inhibitor of
platelet aggregation and cell migration, NO is also an anti-
mitogen [21-23]. In a study using endothelial cells and
SMCs from coronary arteries, inhibition of NO has been
shown to cause an increase in the concentration of colla-
gen types I and III. The data also supports an inhibitory
role for NO on collagen synthesis [24]. Extrapolating
these findings to the present study, it is tempting to pos-
tulate that the attenuation of the proliferative response in
cardiac fibroblasts is the result of increased release of NO
from EECs on treatment with TNF-α or LPS.
Levels of endothelin (ET-1) in the conditioned medium
from EECs treated with TNF-∝ or LPS were found to be
lower, raising the possibility that a decrease in the levels
of ET-1 may contribute to the diminished proliferative
response in fibroblasts. Our earlier studies using endothe-
lin inhibitors had shown that the stimulatory effect of
EECs on cardiac fibroblasts is mediated by ET-1 [5].
Treatment of EECs with TNF-∝ also resulted in an eleva-
tion of TGF-β in the conditioned medium. Dose-depend-
ent increase in TGF-β release has been observed in
microglial cells treated with TNF-∝ [25]. It is possible that
TNF-∝ may regulate TGF-β expression as a feed back
mechanism to limit extra cellular degradation in response
to injury. TGF-β being inhibitory to cardiac fibroblast pro-
liferation, the increased levels of this peptide in the condi-
tioned medium from TNF-∝ treated EECs obviously
accentuates the attenuation of proliferation brought
about by increased NO and decreased ET-1.
LPS causes cardiac dysfunction by enhancing cardiac-
derived inflammatory mediator expression, associated
with the release of pro-inflammatory cytokines such as
TNF-α and IL-1β and over production of NO [26,27].
Human coronary endothelial cells stimulated with LPS
express higher levels of TNF mRNA and release increased
levels of the cytokine [28]. Since most of the effects of LPS
are through TNF, it can be assumed that in cardiac fibrob-
lasts, the endotoxin elicits responses similar to that
induced by TNF-α.
In this study, we have explored the independent effects of
TNF-α and LPS on fibroblast function mediated through
major mediators released by EECs. It is possible that other
EE-derived mediators are also involved in the modulation
of fibroblast growth and collagen synthesis. A limitation
of the study is the usage of cells from two different species,
but in previous studies on the interaction of endothelial
cells with their neighboring cells, others have also
employed cells derived from different species [12].
Conclusion
This study suggests that pro-inflammatory cytokines can
cause altered expression of paracrine factors in EECs, that
in turn may inhibit proliferation and lower collagen syn-
thesis in cardiac fibroblasts. The effects of TNF-α or LPS on
EECs as observed in our study may be of significance in
pathological conditions such as cardiac failure and during
post inflammatory wound healing where different
cytokines are up – regulated in the tissues.
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